Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Return to work following laparoscopic-assisted resection or open resection for rectal cancer: Findings from AlaCaRT-Australasian Laparoscopic Cancer of the Rectum Trial.
Law CK, Brewer K, Brown C, Wilson K, Bailey L, Hague W, Simes JR, Stevenson A, Solomon M, Morton RL; Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT investigators. Law CK, et al. Among authors: simes jr. Cancer Med. 2021 Jan;10(2):552-562. doi: 10.1002/cam4.3623. Epub 2020 Dec 6. Cancer Med. 2021. PMID: 33280266 Free PMC article. Clinical Trial.
Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT).
Law CK, Stevenson ARL, Solomon M, Hague W, Wilson K, Simes JR, Morton RL; Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT Investigators. Law CK, et al. Among authors: simes jr. Ann Surg Oncol. 2022 Mar;29(3):1923-1934. doi: 10.1245/s10434-021-10902-5. Epub 2021 Oct 28. Ann Surg Oncol. 2022. PMID: 34713371 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 35013856
ASO Author Reflections: Is laparoscopic-Assisted Surgery More Costly than Traditional Open Resection for Rectal Cancer Treatment?
Law CK, Stevenson ARL, Solomon M, Hague W, Wilson K, Simes JR, Morton RL; Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT investigators. Law CK, et al. Among authors: simes jr. Ann Surg Oncol. 2022 Mar;29(3):1935-1936. doi: 10.1245/s10434-021-11056-0. Epub 2022 Jan 13. Ann Surg Oncol. 2022. PMID: 35022901 No abstract available.
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer.
Price TJ, Bruhn MA, Lee CK, Hardingham JE, Townsend AR, Mann KP, Simes J, Weickhardt A, Wrin JW, Wilson K, Gebski V, Van Hazel G, Robinson B, Cunningham D, Tebbutt NC. Price TJ, et al. Br J Cancer. 2015 Mar 17;112(6):963-70. doi: 10.1038/bjc.2015.37. Br J Cancer. 2015. PMID: 25742472 Free PMC article. Clinical Trial.
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma.
Mercieca-Bebber R, Barnes EH, Wilson K, Samoon Z, Walpole E, Mai T, Ackland S, Burge M, Dickie G, Watson D, Leung J, Wang T, Bohmer R, Cameron D, Simes J, Gebski V, Smithers M, Thomas J, Zalcberg J, Barbour AP. Mercieca-Bebber R, et al. BMC Cancer. 2022 Mar 15;22(1):276. doi: 10.1186/s12885-022-09270-4. BMC Cancer. 2022. PMID: 35291965 Free PMC article. Clinical Trial.
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Grimison P, Mersiades A, Kirby A, Lintzeris N, Morton R, Haber P, Olver I, Walsh A, McGregor I, Cheung Y, Tognela A, Hahn C, Briscoe K, Aghmesheh M, Fox P, Abdi E, Clarke S, Della-Fiorentina S, Shannon J, Gedye C, Begbie S, Simes J, Stockler M. Grimison P, et al. Ann Oncol. 2020 Nov;31(11):1553-1560. doi: 10.1016/j.annonc.2020.07.020. Epub 2020 Aug 13. Ann Oncol. 2020. PMID: 32801017 Free article. Clinical Trial.
The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer.
Barbour AP, Samra JS, Haghighi KS, Donoghoe MW, Burge M, Harris MT, Chua YJ, Mitchell J, O'Rourke N, Chan H, Gebski VJ, Gananadha S, Croagh DG, Kench JG, Goldstein D; Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators. Barbour AP, et al. Ann Surg Oncol. 2020 Jul;27(7):2506-2515. doi: 10.1245/s10434-020-08205-2. Epub 2020 Jan 29. Ann Surg Oncol. 2020. PMID: 31997125 Clinical Trial.
40 results